 |
|
|
|
|
Argos Overview
Argos Therapeutics, Inc. is developing breakthrough immunotherapies
that target unique features of a patient’s disease. This new generation
of personalized cancer and infectious disease therapeutics trains the
immune system to recognize and attack the disease. Argos’ scientific
leadership in RNA-loaded dendritic cells and advanced manufacturing processes
provide a platform to tackle virtually all forms of cancers and infectious
diseases.
Argos, a private biotechnology company, is headquartered in Research
Triangle Park, NC. The Company has clinical trial programs in cancer
and and human immunodeficiency virus (HIV) and has an ongoing co-development
and commercialization alliance with the Pharmaceutical Division of Kirin
Brewery Company, Limited.
Product Pipeline
View a company backgrounder for more detailed information on
the Argos business and approach.
View
a list of upcoming conferences in which Argos will participate.
|
|
 |
|
